Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

PURPOSE: Metastatic breast cancer patients are usually exposed to taxane and anthracycline as neoadjuvant, adjuvant and palliative chemotherapeutic agents. This study was designed to determine the efficacy and safety of the use of a gemcitabine and cisplatin (GP) combination treatment in patients wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Jung Hwan, Oh, Sung Yong, Kwon, Hyuk-Chan, Lee, Suee, Kim, Sung-Hyun, Kim, Dae-Cheol, Lee, Jin-Hwa, Lee, Hyung-Sik, Cho, Se-Heun, Kim, Hyo-Jin
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2008
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697461/
https://ncbi.nlm.nih.gov/pubmed/19688114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2008.40.3.101
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars